Overview
Sri Yadlapalli is a Hematologist practicing medicine in Ann Arbor, Michigan.
Dr. Yadlapalli is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Multiple Myeloma, and Chronic Myelogenous Leukemia (CML).
She is actively involved in clinical research, co-authoring 4 peer reviewed articles. Dr. Yadlapalli is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.
Rogel Cancer Center
Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Hematology and Internal Medicine. Dr. Campagnaro is currently accepting new patients.
Frequently Asked Questions about Dr. Sri B. Yadlapalli
How do I make an appointment with Dr. Sri B. Yadlapalli?
You can book an appointment with Dr. Sri B. Yadlapalli by calling their office at 248-858-2270. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sri B. Yadlapalli a top-rated expert for Large-Cell Immunoblastic Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sri B. Yadlapalli is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sri B. Yadlapalli specialize in?
While Dr. Sri B. Yadlapalli is a Hematology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Sri B. Yadlapalli participate in research or clinical trials?
Yes. Dr. Sri B. Yadlapalli has published 4 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Sri B. Yadlapalli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sri B. Yadlapalli accept my insurance?
Dr. Sri B. Yadlapalli accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 248-858-2270 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Yadlapalli isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Large-Cell Immunoblastic LymphomaDr. Yadlapalli isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Multiple MyelomaDr. Yadlapalli isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Adult Immune ThrombocytopeniaDr. Yadlapalli isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Yadlapalli isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Yadlapalli isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Yadlapalli isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Yadlapalli isExperienced. Learn about Antiphospholipid Syndrome.
- Autoimmune Hemolytic AnemiaDr. Yadlapalli isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Childhood Acute Myeloid LeukemiaDr. Yadlapalli isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Yadlapalli isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Yadlapalli isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Yadlapalli isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Deep Vein ThrombosisDr. Yadlapalli isExperienced. Learn about Deep Vein Thrombosis.
- Essential ThrombocythemiaDr. Yadlapalli isExperienced. Learn about Essential Thrombocythemia.
- Follicular LymphomaDr. Yadlapalli isExperienced. Learn about Follicular Lymphoma.
- Hemangioma Thrombocytopenia SyndromeDr. Yadlapalli isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Immune Thrombocytopenic Purpura (ITP)Dr. Yadlapalli isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- LeukocytosisDr. Yadlapalli isExperienced. Learn about Leukocytosis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Dr. Yadlapalli isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Yadlapalli isExperienced. Learn about Myelofibrosis.
- Philadelphia-Negative Chronic Myeloid LeukemiaDr. Yadlapalli isExperienced. Learn about Philadelphia-Negative Chronic Myeloid Leukemia.
- Polycythemia VeraDr. Yadlapalli isExperienced. Learn about Polycythemia Vera.
- Pulmonary EmbolismDr. Yadlapalli isExperienced. Learn about Pulmonary Embolism.
- Richter SyndromeDr. Yadlapalli isExperienced. Learn about Richter Syndrome.
- Schnitzler SyndromeDr. Yadlapalli isExperienced. Learn about Schnitzler Syndrome.
- Sickle Cell DiseaseDr. Yadlapalli isExperienced. Learn about Sickle Cell Disease.
- Smoldering Multiple MyelomaDr. Yadlapalli isExperienced. Learn about Smoldering Multiple Myeloma.
- SplenomegalyDr. Yadlapalli isExperienced. Learn about Splenomegaly.
- ThrombocytopeniaDr. Yadlapalli isExperienced. Learn about Thrombocytopenia.


